These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2457318)

  • 1. Preoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with pelvic masses: discrimination of benign from malignant disease.
    Malkasian GD; Knapp RC; Lavin PT; Zurawski VR; Podratz KC; Stanhope CR; Mortel R; Berek JS; Bast RC; Ritts RE
    Am J Obstet Gynecol; 1988 Aug; 159(2):341-6. PubMed ID: 2457318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative evaluation of serum CA 125 levels in patients with primary epithelial ovarian cancer.
    Einhorn N; Bast RC; Knapp RC; Tjernberg B; Zurawski VR
    Obstet Gynecol; 1986 Mar; 67(3):414-6. PubMed ID: 2418395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of CA 125 for ovarian carcinoma in patients presenting with pelvic masses.
    O'Connell GJ; Ryan E; Murphy KJ; Prefontaine M
    Obstet Gynecol; 1987 Dec; 70(6):930-2. PubMed ID: 3479735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of serum CA 125, clinical impression, and ultrasound in the preoperative evaluation of ovarian masses.
    Finkler NJ; Benacerraf B; Lavin PT; Wojciechowski C; Knapp RC
    Obstet Gynecol; 1988 Oct; 72(4):659-64. PubMed ID: 3047614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CA 125 assay used in conjunction with CA 15-3 and TAG-72 assays for discrimination between malignant and non-malignant diseases of the ovary.
    Einhorn N; Knapp RC; Bast RC; Zurawski VR
    Acta Oncol; 1989; 28(5):655-7. PubMed ID: 2590540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative serum tumor-associated antigen levels in women with pelvic masses.
    Soper JT; Hunter VJ; Daly L; Tanner M; Creasman WT; Bast RC
    Obstet Gynecol; 1990 Feb; 75(2):249-54. PubMed ID: 2300353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum CA 125 levels in preoperative evaluation of pelvic masses.
    Vasilev SA; Schlaerth JB; Campeau J; Morrow CP
    Obstet Gynecol; 1988 May; 71(5):751-6. PubMed ID: 3162763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective multicenter study on CA 125 in postmenopausal pelvic masses.
    Maggino T; Gadducci A; D'Addario V; Pecorelli S; Lissoni A; Stella M; Romagnolo C; Federghini M; Zucca S; Trio D
    Gynecol Oncol; 1994 Aug; 54(2):117-23. PubMed ID: 8063233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of CA 125 levels in differentiating malignant from benign tumors in patients with pelvic masses.
    Chen DX; Schwartz PE; Li XG; Yang Z
    Obstet Gynecol; 1988 Jul; 72(1):23-7. PubMed ID: 3164105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CA 125 in the diagnosis of pelvic masses.
    Mogensen O; Mogensen B; Jakobsen A
    Eur J Cancer Clin Oncol; 1989 Aug; 25(8):1187-90. PubMed ID: 2767108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum CA 125 levels in a group of nonhospitalized women: relevance for the early detection of ovarian cancer.
    Zurawski VR; Broderick SF; Pickens P; Knapp RC; Bast RC
    Obstet Gynecol; 1987 Apr; 69(4):606-11. PubMed ID: 2434895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of CA 125 in preoperative diagnosis of patients with pelvic masses.
    Finkler NJ
    Eur J Obstet Gynecol Reprod Biol; 1993 Apr; 49(1-2):105-7. PubMed ID: 8365503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experiences with CA 125, a tumor marker for malignant epithelial ovarian tumors].
    Crombach G; Zippel HH; Würz H
    Geburtshilfe Frauenheilkd; 1985 Apr; 45(4):205-12. PubMed ID: 2408962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CA 125 in preoperative evaluation of pelvic masses.
    Pyrgiotis E; Salamalekis E; Loghis C; Dima C; Zourlas PA
    Eur J Gynaecol Oncol; 1993; 14(4):279-82. PubMed ID: 8344320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of CA 125 for ovarian carcinoma in patients presenting with pelvic masses.
    Patsner B; Mann WJ; Chalas E
    Obstet Gynecol; 1988 Jun; 71(6 Pt 1):949-50. PubMed ID: 3163416
    [No Abstract]   [Full Text] [Related]  

  • 16. Estimation of probability of malignancy using a logistic model combining physical examination, ultrasound, serum CA 125, and serum CA 72-4 in postmenopausal women with a pelvic mass: an international multicenter study.
    Schutter EM; Sohn C; Kristen P; Möbus V; Crombach G; Kaufmann M; Caffier H; Kreienberg R; Verstraeten AA; Kenemans P
    Gynecol Oncol; 1998 Apr; 69(1):56-63. PubMed ID: 9570999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative evaluation of D-dimer and CA 125 levels in differentiating benign from malignant ovarian masses.
    Gadducci A; Baicchi U; Marrai R; Ferdeghini M; Bianchi R; Facchini V
    Gynecol Oncol; 1996 Feb; 60(2):197-202. PubMed ID: 8631538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical significance of pre-operative serum CA 125 in ovarian cancer.
    Cruickshank DJ; Fullerton WT; Klopper A
    Br J Obstet Gynaecol; 1987 Jul; 94(7):692-5. PubMed ID: 2441738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CA 125 in the follow-up of patients with ovarian cancer.
    Koelbl H; Schieder K; Neunteufel W; Bieglmayer C
    Eur J Obstet Gynecol Reprod Biol; 1988 Apr; 27(4):335-42. PubMed ID: 3164284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of pelvic examination, ultrasound, and serum CA 125 in postmenopausal women with a pelvic mass. An international multicenter study.
    Schutter EM; Kenemans P; Sohn C; Kristen P; Crombach G; Westermann R; Môbus V; Kaufmann M; Caffier H; Schmidt-Rhode P
    Cancer; 1994 Aug; 74(4):1398-406. PubMed ID: 8055463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.